Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Takashi Yamatodani is active.

Publication


Featured researches published by Takashi Yamatodani.


Cancer | 2014

Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.

Yuki Misawa; Kiyoshi Misawa; Takeharu Kanazawa; Takayuki Uehara; Shori Endo; Daiki Mochizuki; Takashi Yamatodani; Thomas E. Carey; Hiroyuki Mineta

There is accumulating evidence that galanin receptors (GALRs) may be tumor suppressors in head and neck squamous cell carcinoma (HNSCC). Promoter methylation status and gene expression were assessed in a large panel of head and neck primary tumors, based on the hypothesis that cytosine‐guanine dinucleotide (CpG) hypermethylation might silence the galanin receptor 2 (GALR2) gene.


Acta Oto-laryngologica | 2016

The effect of ventilation tube insertion or trans-tympanic silicone plug insertion on a patulous Eustachian tube

Shiori Endo; Kunihiro Mizuta; Goro Takahashi; Hiroshi Nakanishi; Takashi Yamatodani; Kiyoshi Misawa; Seiji Hosokawa; Hiroyuki Mineta

Abstract Conclusions This study suggests that long-term ventilation tube insertion is the first-choice surgical treatment for a ‘sniff-type’ patulous Eustachian tube (PET). When treating a refractory PET, it is important to determine whether the patient had a habitual sniff. Objectives PET patients were divided into two groups: patients with a habitual sniff (sniff-type PET) and those without a habitual sniff (non-sniff-type PET). This study examined the effects of ventilation tube insertion or silicone plug insertion in each group. Methods Surgical procedures such as ventilation tube insertion or trans-tympanic silicone plug insertion were performed for these patients. Tubotympanoaero-dynamic graphy (TTAG) was also performed to determine the mechanisms underlying these treatments. Results There were 11 cases (17 ears) of sniff-type PET and 20 cases (27 ears) of non-sniff-type PET. An improvement in symptoms was found in 72.7% of the patients who underwent silicone plug insertion (66.7% for sniff-type PET and 74.1% for non-sniff-type PET) and in 90.9% of the patients who underwent ventilation tube insertion for sniff-type PET. In TTAG assessments, many sniff-type PET patients showed significant synchronous changes at high levels of pressure (over 40 daPa) in the external auditory meatus and nasopharynx when performing a slight Valsalva manoeuvre (below 200 daPa).


SpringerPlus | 2016

Human papillomavirus-associated small cell carcinoma/neuroendocrine carcinoma of the oropharynx: a report of two cases

Kiyoshi Misawa; Hideya Kawasaki; Rieko Matsuo; Kenichi Sugiyama; Daiki Mochizuki; Shiori Endo; Atushi Imai; Yuki Misawa; Takashi Yamatodani; Kunihiro Mizuta; Hiroyuki Mineta

IntroductionSmall cell carcinoma/neuroendocrine carcinoma (SCNEC) of the oropharynx is uncommon. Two cases of SCNEC in an 81-year-old woman and in a 54-year-old man are presented here.Case descriptionWe have documented two cases of SCNEC arising in the oropharynx with evidence of high-risk human papillomavirus (HPV) infection. Histologically, both cases were classified as poorly differentiated SCNEC with high nuclear-to-cytoplasmic ratios and nuclear molding. Observations using a transmission electron microscope revealed membrane-bound neuroendocrine granules in some tumor cells. Both tumors expressed high levels of p16, a surrogate marker for high-risk HPV infection. HPV infection was confirmed in both cases using HPV polymerase chain reaction analysis; HPV subtype 16 was identified in one case and HPV subtype 18 in the other.Discussion and EvaluationSCNEC of the oropharynx is a rare and novel HPV-associated disease with neuroendocrine granules and aggressive clinical behavior.ConclusionsHerein, we present two cases of SCNEC, focusing on its histologic features and treatment modalities. More studies are required to elucidate the pathophysiology of HPV-associated SCNEC in different organ systems.


Journal of Laryngology and Otology | 2016

Survival outcomes after surgical resection of pulmonary metastases of head and neck tumours.

Seiji Hosokawa; K Funai; Kenichi Sugiyama; Goro Takahashi; Jun Okamura; Yoshinori Takizawa; Takashi Yamatodani; Hiroyuki Mineta

BACKGROUND There is limited information available regarding the benefits and outcomes of resection of pulmonary metastases arising from head and neck cancers. METHODS A retrospective review was performed of 21 patients who underwent resection of pulmonary metastases of primary head and neck malignancies at Hamamatsu University Hospital. Clinical staging, treatment methods, pathological subtype (particularly squamous cell carcinoma), disease-free interval and overall survival were evaluated. RESULTS The 5- and 10-year overall survival rates of the study participants were 67.0 per cent and 55.0 per cent, respectively, as determined by the Kaplan-Meier method. The prognosis for patients with a disease-free interval of less than 24 months was poor compared to those with a disease-free interval of greater than 24 months (p = 0.0234). CONCLUSION Patients with short disease-free intervals, and possibly those who are older than 60 years, should be categorised as having severe disease. However, pulmonary metastases from head and neck malignancies are potentially curable by surgical resection.


Auris Nasus Larynx | 2017

A case of improved hearing with cochlear implantation in Gaucher disease type 1

Shiori Endo; Kunihiro Mizuta; Takashi Yamatodani; Hiroshi Nakanishi; Kumiko Hosokawa; Kiyoshi Misawa; Seiji Hosokawa; Hiroyuki Mineta

Gaucher disease is a lysosomal storage disorder that is caused by congenital defective function of the enzyme glucocerebrosidase. Glucocerebroside that is not hydrolyzed by glucocerebrosidase mainly accumulates in the reticular tissue. We describe a Japanese boy with Gaucher disease type 1 who developed bilateral profound sensorineural hearing loss within approximately 4years. We performed cochlear implantation initially on his right ear and again on his left ear 5 months later. The cochlear implants were successfully utilized with a speech discrimination score of 95% on a Japanese sentence recognition test. There are many reports of central hearing loss in Gaucher disease type 2 or 3. However, to the best of our knowledge, this is the first report of profound inner ear hearing loss with Gaucher disease. It also appears to be the first record of cochlear implantation for Gaucher disease. Cochlear implants may be useful for sensorineural hearing loss in patients with Gaucher disease without neurological symptoms other than hearing loss.


Acta Oto-laryngologica | 2013

Relationship between tympanic membrane retraction and habitual sniffing in patients with cholesteatoma.

Yoshinori Takizawa; Kunihiro Mizuta; Noboru Hamada; Takashi Yamatodani; Hiroshi Nakanishi; Kumiko Hosokawa; Goro Takahashi; Kenichi Sugiyama; Hiroyuki Mineta

Abstract Conclusion: Habitual sniffing affects the pathogenicity and recurrence of cholesteatoma. Postoperative instructions requesting patients to cease sniffing may reduce the retraction and recurrence of cholesteatoma. Objective: To examine the relationship between tympanic membrane retraction and habitual sniffing in patients with cholesteatoma. Methods: We recruited 98 patients (102 ears) who were surgically treated for cholesteatoma by canal wall-down tympanoplasty (22 ears) or canal wall-down tympanoplasty with reconstruction methods (80 ears). We classified these patients into two groups on the basis of their preoperative habitual sniffing: habitual and non-habitual sniffers. The findings of the contralateral tympanic membrane were examined in each group and were classified according to the Tos classifications. Next, we evaluated the incidence of 1-year postoperative tympanic membrane retraction treated by the canal-down tympanoplasty with reconstruction method in the following three groups: non-habitual sniffing group, sniffing cessation group, and continual sniffing group. Results: In habitual sniffers, the Tos classifications of contralateral tympanic membrane were normal in 7% (3/41). In contrast, for non-habitual sniffers, the findings were normal in 39% (21/54). These results indicate that sniffing causes tympanic membrane retraction. The tympanic membranes of patients in the sniffing cessation group were largely normal after surgery. However, more than 50% of the patients who continued to sniff after surgery showed retraction or recurrent cholesteatoma.


SpringerPlus | 2016

Late recurrence of breast carcinoma metastasis to the hypopharynx: a case report

Chisako Izumi; Kiyoshi Misawa; Shiori Endo; Kenichi Sugiyama; Daiki Mochizuki; Atsushi Imai; Masato Mima; Yuki Misawa; Takashi Yamatodani; Hiroyuki Mineta

BackgroundWe report a rare case of a patient with a hypopharyngeal metastasis from breast cancer.Case presentationIsolated breast cancer metastasis to the hypopharynx has been previously reported in only one autopsy case. Herein, we report a 56-year-old woman with metastases to the hypopharynx almost 24 years after receiving a mastectomy and chemotherapy to treat primary breast carcinoma. We believe that she is the first patient to be treated for metastatic breast carcinoma to the hypopharynx. The hypopharyngeal tumor reduced in size after administration of an oral aromatase inhibitor. The patient has remained alive with a preserved larynx for three years.ConclusionsBreast cancer metastasis to the hypopharynx is an extremely rare event.


Journal of Surgical Research | 2015

Quantitative assessment of the free jejunal graft perfusion.

Kinji Kamiya; Naoki Unno; Shinichiro Miyazaki; Masaki Sano; Hirotoshi Kikuchi; Yoshihiro Hiramatsu; Manabu Ohta; Takashi Yamatodani; Hiroyuki Mineta; Hiroyuki Konno


Practica oto-rhino-laryngologica | 2013

A Case of Descending Necrotizing Mediastinitis

Momoko Kageyama; Yoshinori Takizawa; Kenichi Sugiyama; Goro Takahashi; Kiyoshi Misawa; Takashi Yamatodani; Seiji Hosokawa; Hiroyuki Mineta


Practica oto-rhino-laryngologica | 2013

A Case of Carcinoid Tumor of the Ear

Takashi Yamatodani; Kunihiro Mizuta; Hiroshi Nakanishi; Kenichi Sugiyama; Yoshinori Takizawa; Kumiko Hosokawa; Hiroyuki Mineta

Collaboration


Dive into the Takashi Yamatodani's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge